Stocks News

LAST PRICE
74.1200
TODAY'S CHANGE (%)
Trending Up0.1900 (0.2570%)

Bid / Lots
72.4700/ 2
Ask / Lots
75.0000/ 12
Open / Previous Close
73.9100 / 73.9300
Day Range
Low 73.2800
High 74.6750
52 Week Range
Low 50.2700
High 74.6750
Volume
2,024,269
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Incyte Is Maintained at Equal-Weight by Wells Fargo, from 3:43PM ET on Wednesday Oct 30, 2024 by Dow Jones
  3:43PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: INCY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 15:43 ET (19:43 GMT)
- DJ Incyte Is Maintained at Buy by Citigroup, from 2:45PM ET on Wednesday Oct 30, 2024 by Dow Jones
  2:45PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: INCY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 14:45 ET (18:45 GMT)
- DJ Incyte Is Maintained at Equal-Weight by Morgan Stanley, from 1:43PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:43PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: INCY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 13:43 ET (17:43 GMT)
- DJ Incyte Is Maintained at Neutral by Goldman Sachs, from 1:14PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:14PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: INCY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 13:14 ET (17:14 GMT)
- DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 12:40PM ET on Wednesday Oct 30, 2024 by Dow Jones
  12:40PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: INCY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 12:40 ET (16:40 GMT)

Today
- DJ Genmab A/S Stock Falls Thursday, Underperforms Market, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: GMAB
Yesterday
- DJ Exact Sciences Is Maintained at Outperform by Bernstein, from 3:07PM ET on Wednesday Oct 30, 2024 by Dow Jones
  3:07PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: EXAS
- DJ BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup, from 2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones
  2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Overweight by Cantor Fitzgerald, from 1:25PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:25PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ Genmab A/S Stock Falls Wednesday, Underperforms Market, from 1:02PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:02PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: GMAB
- DJ BioMarin Pharmaceutical Is Maintained at Overweight by JP Morgan, from 12:56PM ET on Wednesday Oct 30, 2024 by Dow Jones
  12:56PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Price Target Maintained With a $80.00/Share by RBC Capital, from 11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN
- UBS Adjusts Price Target on BioMarin Pharmaceutical to $106 From $104, Maintains Buy Rating, from 11:04AM ET on Wednesday Oct 30, 2024 by MT Newswires
  11:04AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Is Maintained at Outperform by Evercore ISI Group, from 10:35AM ET on Wednesday Oct 30, 2024 by Dow Jones
  10:35AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: BMRN

Incyte Corp
NASDAQ:INCYUnited States

Search Criteria

Yesterday

DJ Incyte Is Maintained at Equal-Weight by Wells Fargo, from 3:43PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ Incyte Is Maintained at Buy by Citigroup, from 2:45PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ Incyte Is Maintained at Equal-Weight by Morgan Stanley, from 1:43PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ Incyte Is Maintained at Neutral by Goldman Sachs, from 1:14PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 12:40PM ET on Wednesday Oct 30, 2024 by Dow Jones

Peers Headlines

Today

DJ Genmab A/S Stock Falls Thursday, Underperforms Market, from 8 hours ago by Dow Jones

Yesterday

DJ Exact Sciences Is Maintained at Outperform by Bernstein, from 3:07PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup, from 2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Overweight by Cantor Fitzgerald, from 1:25PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ Genmab A/S Stock Falls Wednesday, Underperforms Market, from 1:02PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Overweight by JP Morgan, from 12:56PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Price Target Maintained With a $80.00/Share by RBC Capital, from 11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

UBS Adjusts Price Target on BioMarin Pharmaceutical to $106 From $104, Maintains Buy Rating, from 11:04AM ET on Wednesday Oct 30, 2024 by MT Newswires

DJ BioMarin Pharmaceutical Is Maintained at Outperform by Evercore ISI Group, from 10:35AM ET on Wednesday Oct 30, 2024 by Dow Jones